Dalit BJP MP alleges discrimination by CM Yogi, other senior leaders

Agencies
April 5, 2018

Lucknow, Apr 5: The BJP was left red-faced after yet another Dalit MP of the party accused the leadership and Uttar Pradesh Chief Minister Yogi Adityanath of "humiliating" him and sought prime minister Narendra Modi's intervention.

BJP Lok Sabha member from Robertsganj in the state's tribal-dominated Sonebhadra district, about 450 km from here, Chotelal Kharwar has written to Modi stating in detail about his humiliation and discrimination by his party colleagues, including senior state functionaries, administration and Adityanath, and urged him to take steps to restore his dignity.

The Dalit lawmaker said in the letter that the administration had hatched a conspiracy to get him evicted from his house by declaring it forest property.

He also accused his party colleagues of colluding with the rival parties.

"I met Adityanath to apprise him of the matter but he threw me out," Kharwar claimed.

Kharwar's outbursts against the state government and party colleagues came within days after Dalit saffron party MP from Baharaich constituency Savitri Bai Phule also accused the party leadership of conspiring to scrape reservation.

Savitri also organised a rally here a few days ago in which she expressed similar apprehensions.

Chotelal's allegations against Adityanath, in particular, put the BJP in an embarrassing situation as a similar charge was made a city-based trader as well.

The trader Ayush Singhal had also accused Adityanath of throwing him out of the latter's "Janata Darbar" after he complained to him that controversial independent MLA Aman Mani Tripathi had illegally grabbed his (trader) precious land.

"Maharajji (Adityanath) ne meri application phenk di...bole tera kaam zindagi mein nahin hoga," (he threw away my application and said that it will not be acted upon in this life), Singhal claimed.

Incidentally, Aman Mani, who is the son of murder convict former Uttar Pradesh minister Amar Mani Tripathi, was himself an accused in the murder of his wife.

He had voted for the BJP in the recently concluded Rajya Sabha biennial polls in Uttar Pradesh.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 20,2020

New Delhi, Jun 20: With the highest single-day increase of 14,516 COVID-19 cases reported in the last 24 hours, India's coronavirus count stood at 3,95,048 on Saturday.

The death toll has gone up to 12,948 in the country with 375 persons succumbing to the infection.

According to the Union Ministry of Health and Family Welfare, the total number of cases includes 1,68,269 active cases, 2,13,831 cured/discharged/migrated and 12,948 deaths.

Maharashtra with 1,24,331 cases continues to be the worst-affected state in the country with 55,665 active cases while 62,773 patients have been cured and discharged in the state so far. The death toll due to COVID-19 stands at 5,893 in the state.

The number of confirmed cases in Tamil Nadu also crossed the 50 thousand mark on Saturday and reached 54,449.

The national capital is the third-worst affected by the infection in the country with the count reaching 53,116 today.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

New Delhi, Jun 2: India on Tuesday reported 8,171 more COVID-19 cases and 204 deaths in the last 24 hours as the country's virus count inches closer to two lakh, according to the Union Ministry of Health and Family Welfare.

The total number of cases in the country now stands at 1,98,706 including 97,581 active cases, 95,527 cured/discharged/migrated and 5,598 deaths.

Cases in Maharashtra have crossed 70,000 including over 30,000 recovered while Tamil Nadu's COVID-19 tally jumped to 23,495.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.